1. What Is the Mammography Systems Market?
The Mammography Systems Market covers dedicated breast imaging systems for cancer screening and diagnostic evaluation including digital mammography, digital breast tomosynthesis, automated breast ultrasound, and contrast-enhanced mammography. Radiologists, breast imaging specialists, and screening program administrators deploy mammography systems for population-based breast cancer screening programs, diagnostic evaluation of abnormalities, and surgical guidance. The market includes 2D digital mammography, 3D digital breast tomosynthesis, and AI-integrated breast cancer detection systems.
2. Mammography Systems Market Size & Forecast
3. Emerging Technologies
- Photon-counting mammography providing superior contrast and dose reduction through spectral imaging for improved dense breast evaluation.
- AI-powered breast cancer risk prediction integrating mammographic texture features with genetic and clinical risk factors for personalized screening recommendations.
- Contrast-enhanced spectral mammography providing full-field dual-energy acquisition for lesion enhancement characterization.
- Automated quantitative volumetric breast density assessment providing reproducible density classification supporting supplemental screening decisions.
Comparable technologies are influencing adjacent market segments in similar ways. Read more in our Mri Systems Market.
4. Key Market Opportunity
Digital breast tomosynthesis replacement of 2D digital mammography represents the largest equipment replacement opportunity. Emerging market mammography program establishment is the largest volume opportunity in global population health. AI mammography software is the fastest-growing add-on revenue category. Contrast-enhanced mammography adoption for dense breast supplemental screening is the fastest-growing clinical application expansion.
5. Top Companies in the Mammography Systems Market
The following organisations hold leading positions in the Mammography Systems Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Hologic
- GE HealthCare
- Siemens Healthineers
- Philips Healthcare
- Fujifilm
- IMS Giotto
- Metaltronica
- Sectra
- Volpara Health
- iCAD
6. Market Segmentation
The Mammography Systems Market is analysed across 4 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By System Type | 2D Digital MammographyDigital Breast Tomosynthesis 3DAutomated Breast UltrasoundContrast-Enhanced MammographyMolecular Breast Imaging |
| By Application | Breast Cancer ScreeningDiagnostic MammographyBiopsy GuidanceDense Breast Evaluation |
| By End-User | Hospital Breast Imaging CentersDedicated Breast CentersMobile Mammography ServicesPopulation Screening Programs |
| By Geography | North AmericaEuropeAsia PacificLatin AmericaMiddle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Mammography Systems Market trajectory over the forecast period:
Digital breast tomosynthesis is completing the replacement of 2D digital mammography as the standard breast cancer screening modality.DBT demonstrating improved cancer detection rates and reduced false-positive recall rates versus 2D mammography is gaining systematic program adoption. Hologic Dimensions and GE SenoClaire systems dominate DBT procurement. The DBT upgrade cycle is creating system replacement demand across hospital and dedicated breast imaging centers globally.
AI-powered mammography reading is creating CAD 2.0 capability substantially superior to first-generation computer-aided detection.AI mammography systems detecting subtle lesions and reducing false-positive recalls are demonstrating radiologist performance augmentation in clinical validation studies. Screenpoint Medical, Transpara, and vendor-integrated AI are deployed across breast screening programs. The AI reading assistance is driving systematic software investment alongside hardware procurement.
Contrast-enhanced mammography is gaining adoption as a cost-effective alternative to MRI for dense breast evaluation and high-risk screening.CEM providing functional vascularity information alongside anatomical mammography imaging at conventional mammography system cost creates accessibility advantage versus dedicated breast MRI. The CEM cost-effectiveness versus MRI is driving adoption as a supplemental screening modality for dense breasts.
For related market intelligence, see the Ultrasound Imaging Market.
8. Segmental Analysis
By system type, the digital breast tomosynthesis segment dominated the Mammography Systems Market in 2025, as DBT demonstrating superior cancer detection versus 2D digital mammography is completing systematic replacement as the breast cancer screening standard across organized screening programs globally.
By application, the dense breast evaluation segment is projected to register the highest growth rate through 2034, as dense breast notification legislation and supplemental screening guideline adoption are driving systematic investment in contrast-enhanced mammography and automated breast ultrasound technologies.
9. Regional Analysis
Regional demand patterns across the Mammography Systems Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America dominated the Mammography Systems Market in 2025, accounting for around 45 percent of global revenue. The United States organized breast cancer screening program infrastructure combined with DBT adoption as the screening standard drives the world's largest mammography market. Hologic maintains the largest U.S. mammography installed base. GE HealthCare, Siemens Healthineers, and iCAD generate substantial U.S. mammography system and AI revenue. Moreover, U.S. dense breast notification laws drive supplemental screening technology adoption.
Highest CAGR Region
Asia Pacific is projected to register the highest CAGR in the Mammography Systems Market through 2034. The region's expanding breast cancer screening program infrastructure combined with growing breast cancer prevalence awareness is driving substantial mammography procurement. Chinese breast screening program expansion creates substantial system demand. Japanese and Korean organized breast screening programs support systematic mammography system renewal and AI integration.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology adoption trends and innovation tracking
- • Custom company profiling and benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country Trade Analysis
- • Country-level opportunity mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • List of Raw Material Suppliers
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Mammography Systems Market was valued at USD 3.85 Bn in 2025 and is projected to reach USD 7.82 Bn by 2034, growing at a CAGR of 8.2% over the 2026–2034 forecast period.
The Mammography Systems Market is projected to grow at a CAGR of 8.2% from 2026 to 2034.
North America dominated the Mammography Systems Market in 2025, accounting for around 45 percent of global revenue.
The leading companies in the Mammography Systems Market include Hologic, GE HealthCare, Siemens Healthineers, Philips Healthcare, Fujifilm, IMS Giotto, Metaltronica, Sectra, Volpara Health, iCAD.
Digital breast tomosynthesis is completing the replacement of 2d digital mammography as the standard breast cancer screening modality.
By system type, the digital breast tomosynthesis segment dominated the Mammography Systems Market in 2025, as DBT demonstrating superior cancer detection versus 2D digital mammography is completing systematic replacement as the breast cancer screening standard across organized screening programs globally.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.